Latest Hodgkin's lymphoma Stories
Marketing Strategies That Educate Payers and Prescribers on Key Benefits of New Drugs Will Maximize Rapid Formulary Inclusion, According to Findings from Decision Resources Group BURLINGTON,
CAMBRIDGE, Mass., June 10, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.
Public Healthcare Systems in Brazil and Mexico Cover Targeted Therapies but with Indication-Specific Restrictions, According to Findings from Decision Resources Group BURLINGTON, Mass., June
Transparency Market Research added a new report "Global Natural Killer Cell Lymphomas Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
- Data include results from two Phase I studies of ABT-199/GDC-0199 in relapsed/refractory chronic lymphocytic leukemia (CLL) and various subtypes of non-Hodgkin's lymphoma (NHL) NORTH
WHITE PLAINS, N.Y., May 19, 2014 /PRNewswire-USNewswire/ -- Foundation Beyond Belief (FBB), a team of atheists, humanists and religious allies, just completed their second year with The Leukemia
Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book,
Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., April 29, 2014 /PRNewswire-iReach/ -- In his new book,
- First and Only Approved Monotherapy in the EU for this Patient Population - BIRMINGHAM, England, April 29, 2014 /PRNewswire/ -- Cell Therapeutics, Inc.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.